RecruitingNCT07382583

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer


Sponsor

M.D. Anderson Cancer Center

Enrollment

270 participants

Start Date

Feb 12, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a shared decision-making tool to help women decide whether to use a hormonal IUD (a small device placed in the uterus that releases low-dose hormones) as a way to help prevent endometrial (uterine) cancer. Researchers want to gather feedback from both women at increased risk and those who have already had endometrial cancer or its precursor. **You may be eligible if...** - You are 18 years old or older - You speak and read English or Spanish - You are premenopausal (still having periods) - You have not previously been diagnosed with endometrial cancer or complex atypical hyperplasia (a precancerous uterine condition) — OR you are a woman who has had these conditions and meets additional criteria - You are willing to participate in an interview **You may NOT be eligible if...** - You are postmenopausal - You have physical, psychological, or cognitive conditions that would prevent you from participating in an interview - You do not speak English or Spanish Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurvey using a questionnaire

Patient Preference Utility Assessment and Questionnaires


Locations(2)

The Harris Health System (LBJ)

Houston, Texas, United States

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07382583


Related Trials